Cargando…

Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients

BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome (LS) is a cancer syndrome characterised by early-onset epithelial cancers, especially colorectal cancer (CRC) and endometrial cancer. The aim of the current study was to use SNP-array technology to identify genomic aberrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Talseth-Palmer, Bente A, Holliday, Elizabeth G, Evans, Tiffany-Jane, McEvoy, Mark, Attia, John, Grice, Desma M, Masson, Amy L, Meldrum, Cliff, Spigelman, Allan, Scott, Rodney J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626775/
https://www.ncbi.nlm.nih.gov/pubmed/23531357
http://dx.doi.org/10.1186/1755-8794-6-10
_version_ 1782266244554031104
author Talseth-Palmer, Bente A
Holliday, Elizabeth G
Evans, Tiffany-Jane
McEvoy, Mark
Attia, John
Grice, Desma M
Masson, Amy L
Meldrum, Cliff
Spigelman, Allan
Scott, Rodney J
author_facet Talseth-Palmer, Bente A
Holliday, Elizabeth G
Evans, Tiffany-Jane
McEvoy, Mark
Attia, John
Grice, Desma M
Masson, Amy L
Meldrum, Cliff
Spigelman, Allan
Scott, Rodney J
author_sort Talseth-Palmer, Bente A
collection PubMed
description BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome (LS) is a cancer syndrome characterised by early-onset epithelial cancers, especially colorectal cancer (CRC) and endometrial cancer. The aim of the current study was to use SNP-array technology to identify genomic aberrations which could contribute to the increased risk of cancer in HNPCC/LS patients. METHODS: Individuals diagnosed with HNPCC/LS (100) and healthy controls (384) were genotyped using the Illumina Human610-Quad SNP-arrays. Copy number variation (CNV) calling and association analyses were performed using Nexus software, with significant results validated using QuantiSNP. TaqMan Copy-Number assays were used for verification of CNVs showing significant association with HNPCC/LS identified by both software programs. RESULTS: We detected copy number (CN) gains associated with HNPCC/LS status on chromosome 7q11.21 (28% cases and 0% controls, Nexus; p = 3.60E-20 and QuantiSNP; p < 1.00E-16) and 16p11.2 (46% in cases, while a CN loss was observed in 23% of controls, Nexus; p = 4.93E-21 and QuantiSNP; p = 5.00E-06) via in silico analyses. TaqMan Copy-Number assay was used for validation of CNVs showing significant association with HNPCC/LS. In addition, CNV burden (total CNV length, average CNV length and number of observed CNV events) was significantly greater in cases compared to controls. CONCLUSION: A greater CNV burden was identified in HNPCC/LS cases compared to controls supporting the notion of higher genomic instability in these patients. One intergenic locus on chromosome 7q11.21 is possibly associated with HNPCC/LS and deserves further investigation. The results from this study highlight the complexities of fluorescent based CNV analyses. The inefficiency of both CNV detection methods to reproducibly detect observed CNVs demonstrates the need for sequence data to be considered alongside intensity data to avoid false positive results.
format Online
Article
Text
id pubmed-3626775
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36267752013-04-16 Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients Talseth-Palmer, Bente A Holliday, Elizabeth G Evans, Tiffany-Jane McEvoy, Mark Attia, John Grice, Desma M Masson, Amy L Meldrum, Cliff Spigelman, Allan Scott, Rodney J BMC Med Genomics Research Article BACKGROUND: Hereditary non-polyposis colorectal cancer (HNPCC)/Lynch syndrome (LS) is a cancer syndrome characterised by early-onset epithelial cancers, especially colorectal cancer (CRC) and endometrial cancer. The aim of the current study was to use SNP-array technology to identify genomic aberrations which could contribute to the increased risk of cancer in HNPCC/LS patients. METHODS: Individuals diagnosed with HNPCC/LS (100) and healthy controls (384) were genotyped using the Illumina Human610-Quad SNP-arrays. Copy number variation (CNV) calling and association analyses were performed using Nexus software, with significant results validated using QuantiSNP. TaqMan Copy-Number assays were used for verification of CNVs showing significant association with HNPCC/LS identified by both software programs. RESULTS: We detected copy number (CN) gains associated with HNPCC/LS status on chromosome 7q11.21 (28% cases and 0% controls, Nexus; p = 3.60E-20 and QuantiSNP; p < 1.00E-16) and 16p11.2 (46% in cases, while a CN loss was observed in 23% of controls, Nexus; p = 4.93E-21 and QuantiSNP; p = 5.00E-06) via in silico analyses. TaqMan Copy-Number assay was used for validation of CNVs showing significant association with HNPCC/LS. In addition, CNV burden (total CNV length, average CNV length and number of observed CNV events) was significantly greater in cases compared to controls. CONCLUSION: A greater CNV burden was identified in HNPCC/LS cases compared to controls supporting the notion of higher genomic instability in these patients. One intergenic locus on chromosome 7q11.21 is possibly associated with HNPCC/LS and deserves further investigation. The results from this study highlight the complexities of fluorescent based CNV analyses. The inefficiency of both CNV detection methods to reproducibly detect observed CNVs demonstrates the need for sequence data to be considered alongside intensity data to avoid false positive results. BioMed Central 2013-03-26 /pmc/articles/PMC3626775/ /pubmed/23531357 http://dx.doi.org/10.1186/1755-8794-6-10 Text en Copyright © 2013 Talseth-Palmer et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Talseth-Palmer, Bente A
Holliday, Elizabeth G
Evans, Tiffany-Jane
McEvoy, Mark
Attia, John
Grice, Desma M
Masson, Amy L
Meldrum, Cliff
Spigelman, Allan
Scott, Rodney J
Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
title Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
title_full Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
title_fullStr Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
title_full_unstemmed Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
title_short Continuing difficulties in interpreting CNV data: lessons from a genome-wide CNV association study of Australian HNPCC/lynch syndrome patients
title_sort continuing difficulties in interpreting cnv data: lessons from a genome-wide cnv association study of australian hnpcc/lynch syndrome patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3626775/
https://www.ncbi.nlm.nih.gov/pubmed/23531357
http://dx.doi.org/10.1186/1755-8794-6-10
work_keys_str_mv AT talsethpalmerbentea continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT hollidayelizabethg continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT evanstiffanyjane continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT mcevoymark continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT attiajohn continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT gricedesmam continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT massonamyl continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT meldrumcliff continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT spigelmanallan continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients
AT scottrodneyj continuingdifficultiesininterpretingcnvdatalessonsfromagenomewidecnvassociationstudyofaustralianhnpcclynchsyndromepatients